SS-31

SS-31 is a synthetic peptide derived from the amino acid sequence of the bovine heart mitochondrial protective protein, originally identified in 2013. This peptide has garnered significant attention within the scientific community for its potential protective effects against oxidative stress and cellular damage, primarily studied in preclinical research.

Research Context

SS-31 was initially discovered through its ability to prevent cardiomyocyte death in vitro and in animal models of cardiac ischemia-reperfusion injury. Early studies demonstrated its potential role in enhancing mitochondrial function and reducing apoptosis in response to stress, though human applications remain beyond the scope of current research due to its potential metabolic implications.

Research Overview

Research involving SS-31 has primarily focused on its biochemical mechanisms, including interactions with mitochondrial proteins and extracellular matrix components. Its efficacy in models of ischemia has prompted further exploration into its potential utility in neurodegenerative diseases, cardiovascular conditions, and metabolic syndrome. However, translation to clinical use has been hindered by concerns regarding its stability, delivery methods, and potential systemic effects.

Key Research Focus Areas

• Cardioprotection: Investigation into SS-31’s role in mitigating oxidative damage in myocardial infarction models and improving cardiac function post-injury.
• Neuroprotection: Explorations of its potential in reducing neuronal apoptosis in models of stroke, Alzheimer’s disease, and Parkinson’s disease.
• Metabolic and Anti-Aging Effects: Studies assessing its impact on mitochondrial biogenesis, metabolic efficiency, and aging-related decline in preclinical animal studies.
• Extracellular Matrix Stabilization: Research into its effects on collagen and elastin stabilization, relevant to conditions such as fibrosis and arterial stiffness.
• Biochemical Mechanisms: Characterization of SS-31’s interactions with protein targets, including mitochondrial protective pathways and extracellular matrix proteins.

Research on SS-31 is conducted under strict regulatory oversight in academic and industrial settings, with ongoing studies focusing on optimizing its synthesis, formulation, and delivery for potential future applications.

Important Disclaimer

This product is intended solely for research purposes and is not approved for human or animal consumption. SS-31 should only be handled and utilized in accordance with established laboratory protocols and regulatory guidelines applicable to peptide research. Users must adhere to all ethical, safety, and compliance requirements governing its use. No claims are made regarding therapeutic, diagnostic, or cosmetic effects, and results may vary depending on experimental conditions.

For research use only. Not for human or animal consumption.